Title: Participant powered research: Using direct to consumer genetic testing to help us understand COVID-19 host genetics.
Authors: Adam Auton - 23andMe (United States) [presenting]
Abstract: Since its foundation in 2006, 23andMe has worked to help people access, understand, and benefit from the human genome. By enabling people to participate in scientific research, 23andMe has developed the worlds largest consented, re-contactable database for genetic research, with more than 11 million customers, a research consent rate over 80 percent, and billions of phenotypic data points. We will provide an overview of research studies conducted at 23andMe, and outline how we engage our customers in our research. We will discuss the power of the 23andMe database driving scientific discoveries that could lead to novel therapies in a wide range of diseases, and describe how this research model can be deployed for answering questions around COVID-19 host genetics.